Septalyst Lifesciences Private Limited - Company Profile

It is a pharma private limited company based in Thane, Maharashtra, India, established in 2010.
2010 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Septalyst Lifesciences Private Limited

Septalyst Lifesciences Private Limited, a active private limited company, was established on 10 June 2010 in Thane, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74900MH2010PTC203994. Registered under ROC Roc Mumbai Ii. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.23 M.

It upholds a compliant status. Employing 131 professional, Its leadership includes Shyam Sunder Singh (Managing Director), Bhaskar Shivprasad Mamgai (Director), Ajeet Singh (Director). Past directors included Shyam Sunder Singh, Bhaskar Shivprasad Mamgai, Ajeet Singh. It holds ₹17.15 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 801-802, B Wing, Lodha Supremus, Kolshet Road, Thane, Thane, Maharashtra, 400607.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900MH2010PTC203994

  • Registration Number

    203994

  • Incorporation Date

    10 June 2010

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.23 M

  • ROC Code

    Roc Mumbai Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.23 M
  • Company Age 16 Year, 3 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 17.15 Cr
  • Revenue Growth **** 27.97%
  • Profit Growth **** 22.02%
  • Ebitda **** -62.17%
  • Net Worth 4.08%
  • Total Assets **** 18.67%
Company report

Septalyst Lifesciences Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Septalyst Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Septalyst Lifesciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Shyam Sunder Singh Managing Director 10 Jun 2010 Current
Bhaskar Shivprasad Mamgai Director 26 Oct 2021 Current
Ajeet Singh Director 26 Oct 2021 Current
Vishal Gourav Bohidar Director 10 Jun 2010 Current
Yogesh Prabhudyal Sharma Director 10 Jun 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 19 Dec 2018 Past
Pramod Abcsdd Director 29 Nov 2021 Past
Pramod Abcsdd Director 29 Nov 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Septalyst Lifesciences.

Septalyst Lifesciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 27.97% increase. The company also saw a substantial improvement in profitability, with a 22.02% increase in profit. The company's net worth moved up by a moderate rise of 4.08%.

Septalyst Lifesciences revenue growth over time
Septalyst Lifesciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 27.97%
*******
*******
*******
*******
Revenue from Operations
*******
 28.25%
*******
*******
*******
*******
Total Assets
*******
 18.67%
*******
*******
*******
*******
Profit or Loss
*******
 22.02%
*******
*******
*******
*******
Net Worth
*******
 4.08%
*******
*******
*******
*******
EBITDA
*******
 -62.17%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Septalyst Lifesciences?

In 2021, Septalyst Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹171,480,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 15.61 Cr
  • Hdfc Bank Limited : 1.54 Cr
Latest Charge Details
Date Lender Amount Status
02 Jun 2025 Others ₹4.90 Cr Open
02 Jun 2025 Others ₹1.76 Cr Open
27 Jul 2022 Others ₹6.50 Cr Open
27 Jul 2022 Others ₹2.45 Cr Open
08 Feb 2021 Hdfc Bank Limited ₹4.31 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Septalyst Lifesciences?

Septalyst Lifesciences has a workforce of 131 employees as of Dec 16, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Septalyst Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Septalyst Lifesciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Septalyst Lifesciences
Recent Activity within the Organization
  • Annual General Meeting

    The activity Septalyst Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    A charge with Others of Rs. 49.00 M registered on 02 Jun 2025 with Charge ID 101116436 was modified on 29 Jul 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 17.62 M registered on 02 Jun 2025 with Charge ID 101116433 was modified on 29 Jul 2025. was documented.

  • Charges

    A charge with Others amounted to Rs. 49.00 M with Charge ID 101116436 was registered on 02 Jun 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 17.62 M with Charge ID 101116433 was registered on 02 Jun 2025. was documented.

  • Balance Sheet

    Progress on Septalyst Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Septalyst Lifesciences Private Limited?

The CIN of Septalyst Lifesciences Private Limited is U74900MH2010PTC203994.

Where is Septalyst Lifesciences Private Limited headquartered?

Septalyst Lifesciences Private Limited is headquartered at 801-802, B Wing, Lodha Supremus, Kolshet Road, Thane, Thane, Maharashtra, 400607.

When was Septalyst Lifesciences Private Limited incorporated?

Septalyst Lifesciences Private Limited was incorporated on 10 June 2010.

Who are the current directors of Septalyst Lifesciences Private Limited?

The current directors of Septalyst Lifesciences Private Limited are

What is the primary industry of Septalyst Lifesciences Private Limited?

The primary industry of Septalyst Lifesciences Private Limited is Trade.

Is Septalyst Lifesciences Private Limited a listed company?

Septalyst Lifesciences Private Limited is unlisted.

What is the capital structure of Septalyst Lifesciences Private Limited?

The authorized capital of Septalyst Lifesciences Private Limited is ₹0.50 M, and the paid-up capital is ₹0.23 M.

What is the compliance status of Septalyst Lifesciences Private Limited?

The compliance status of Septalyst Lifesciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available